DR. STEPHEN I-HONG HSU, MD, PHD
Osteopathic Medicine at Archer Rd, Gainesville, FL
License number
Florida ME101909
Category
Osteopathic Medicine
Type
Nephrology
License number
Florida 157804
Category
Osteopathic Medicine
Type
Nephrology
Address
Address
2
1600 SW Archer Rd, Gainesville, FL 32610
PO Box 918025, Orlando, FL 32891
PO Box 918025, Orlando, FL 32891
Phone
(352) 273-9180
(352) 265-8244 (Fax)
(352) 265-8244 (Fax)
Personal information
See more information about STEPHEN I-HONG HSU at radaris.comName
Address
Phone
3005 SW 70Th Ln, Gainesville, FL 32608
3005 SW 70Th Ln, Gainesville, FL 32608
3005 70Th St, Gainesville, FL 32608
Gainesville, FL
Professional information
Dr. Stephen I Hsu - MD (Doctor of Medicine)
Hospitals:
1600 SW Archer Rd, Gainesville 32610
Brigham and Women's Hospital
75 Francis St, Boston 02115
1600 SW Archer Rd, Gainesville 32610
Brigham and Women's Hospital
75 Francis St, Boston 02115
Brigham and Women's Hospital
75 Francis St, Boston 02115
1600 SW Archer Rd, Gainesville 32610
Brigham and Women's Hospital
75 Francis St, Boston 02115
Education:
Medical Schools
Albert Einstein College of Medicine of Yeshiva University
Graduated: 1992
Albert Einstein College of Medicine of Yeshiva University
Graduated: 1992
Stephen I-Hong Hsu, Gainesville FL
Specialties:
Nephrologist
Address:
1600 Sw Archer Rd, Gainesville, FL 32610
Education:
Doctor of Medicine
Thermo-Sensitive, Mucoadhesive Or Dermoadhesive, And Penetration-Enhancing Formulations For Topical Delivery Of Therapeutics
US Patent:
2014002, Jan 23, 2014
Filed:
Mar 29, 2012
Appl. No.:
14/008004
Inventors:
Stephen I-Hong Hsu - Gainesville FL, US
Assignee:
UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. - Gainesville FL
International Classification:
A61K 47/34, A61K 47/10, A61K 47/22
US Classification:
424 852, 514788, 424649, 514 27, 514 34, 514 211, 514 209, 514249, 514 59, 514635, 514369, 514592, 514342, 51421711, 51425506, 514423, 514412, 514331, 514563, 514 54, 4241841
Abstract:
The present invention provides thermo-sensitive, mucoadhesive biopolymer formulations that enhance the penetration of therapeutics across the skin or mucosal surfaces. In a preferred embodiment, the biopolymer formulation comprises co-polymer of poloxamer 188 and propylene glycol, laurocapram and, optionally, one or more therapeutic agents. Also provided are uses of the biopolymer formulations for topical therapy of cancer including cervical cancer.